This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

CardioNet, Inc. Reports Fourth Quarter And Full Year 2011 Financial Results

CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the fourth quarter and full year-ended December 31, 2011.

2011 Highlights

  • Achieved positive adjusted EBITDA for the fourth quarter and full year 2011
  • Reduced quarter-end DSO to 75 days
  • Reached an agreement to settle shareholder litigation
  • Implemented over $7 million of annualized cost reductions
  • Launched next-generation MCOT TM device
  • Opened west coast monitoring location
  • Secured 52 new payor contracts covering over 10 million lives
  • Completed Biotel integration and generated positive EBITDA contribution
  • $46.5 million in cash and investments as of December 31, 2011, with no outstanding debt

President and CEO Commentary

Joseph Capper, President and Chief Executive Officer of CardioNet, commented: “During the fourth quarter, we continued to successfully execute on our operational initiatives as evidenced by the positive adjusted EBITDA generated for the quarter and full year 2011. We launched our next-generation MCOT TM device, implemented approximately $7.5 million of annualized cost reductions, reached an agreement to settle the outstanding class action litigation and opened the west coast monitoring facility. We will ramp up our activity in this new facility over the next three months and expect to be fully operational in the second quarter. Given this significant progress, we are now in a far better position to capitalize on a variety of growth opportunities.

“As an example, we recently announced the purchase of ECG Scanning & Medical Services, Inc. (“ECG Scanning”), a $7 million cardiac monitoring company focused on event, Holter and pacemaker monitoring. The acquisition is expected to be accretive in the first year and improve the Company’s position in the cardiac monitoring market by leveraging our infrastructure and ECG Scanning’s customer relationships.

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs